
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+7
Re-Vana Therapeutics is a venture-backed, pioneering therapeutics and ocular drug delivery company developing innovative sustained-release biologics to treat serious retinal diseases. The companys proprietary photo-crosslinked, biodegradable platform technologies, EyeLief, EyeLief SDTM and OcuLief, enable custom delivery of a wide range of therapeutic molecules. Numerous platform capabilities create a therapeutic continuum to expand treatment opportunities through both internal development and external, strategic collaborations. Re-Vana envisions a new industry standard for sustained delivery of biologics to the retina, creating transformative and differentiated treatments for physicians and significantly reducing patient treatment burden
Amd,photo-crosslinking,biologics,drug delivery,retinal disease,polymers,ophthalmology,retina specialist,sustained release,macular degeneration,reduced patient burden,and drug durability
Re-vana therapeutics operates in the Biotechnology research industry.
Re-vana therapeutics's revenue is 11m - 100m
Re-vana therapeutics has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.